AU1998200A - Multiparticulate oral dosage forms - Google Patents
Multiparticulate oral dosage formsInfo
- Publication number
- AU1998200A AU1998200A AU19982/00A AU1998200A AU1998200A AU 1998200 A AU1998200 A AU 1998200A AU 19982/00 A AU19982/00 A AU 19982/00A AU 1998200 A AU1998200 A AU 1998200A AU 1998200 A AU1998200 A AU 1998200A
- Authority
- AU
- Australia
- Prior art keywords
- dosage forms
- oral dosage
- multiparticulate oral
- multiparticulate
- forms
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
- A61K47/585—Ion exchange resins, e.g. polystyrene sulfonic acid resin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
- A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
- A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Zoology (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US11507099P | 1999-01-07 | 1999-01-07 | |
IE990009 | 1999-01-07 | ||
US60115070 | 1999-01-07 | ||
IE990009A IE990009A1 (en) | 1999-01-07 | 1999-01-07 | Taste-masked composition |
PCT/IE2000/000003 WO2000040224A1 (en) | 1999-01-07 | 2000-01-07 | Multiparticulate oral dosage forms |
Publications (1)
Publication Number | Publication Date |
---|---|
AU1998200A true AU1998200A (en) | 2000-07-24 |
Family
ID=26320234
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU19982/00A Abandoned AU1998200A (en) | 1999-01-07 | 2000-01-07 | Multiparticulate oral dosage forms |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP1140037A1 (ja) |
JP (1) | JP2002534374A (ja) |
AU (1) | AU1998200A (ja) |
CA (1) | CA2355829A1 (ja) |
WO (1) | WO2000040224A1 (ja) |
Families Citing this family (38)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20020032245A1 (en) * | 2000-07-27 | 2002-03-14 | Lyn Hughes | Resinate composition |
US20020031490A1 (en) * | 2000-07-27 | 2002-03-14 | Bellamy Simon Andrew | Method for preparing resinates |
US20030059397A1 (en) * | 2001-09-17 | 2003-03-27 | Lyn Hughes | Dosage forms |
EP1467769B1 (en) * | 2002-01-18 | 2008-05-28 | Rohm and Haas Company | Use of a resinate in the preparation of a formulation for smoking cessation |
US7704527B2 (en) | 2002-10-25 | 2010-04-27 | Collegium Pharmaceutical, Inc. | Modified release compositions of milnacipran |
EP1556024A4 (en) * | 2002-10-25 | 2007-01-17 | Collegium Pharmaceutical Inc | INTERMITTENT LIBERATION COMPOSITIONS OF MILNACIPRANE |
US20040121010A1 (en) * | 2002-10-25 | 2004-06-24 | Collegium Pharmaceutical, Inc. | Pulsatile release compositions of milnacipran |
AU2003297736A1 (en) * | 2002-12-23 | 2004-07-29 | Celltech Americas, Inc. | Acid labile drug compositions |
US20040228830A1 (en) * | 2003-01-28 | 2004-11-18 | Collegium Pharmaceutical, Inc. | Multiparticulate compositions of milnacipran for oral administration |
CA2531564C (en) * | 2003-07-18 | 2016-01-19 | Santarus, Inc. | Pharmaceutical composition for inhibiting acid secretion |
US7556799B2 (en) | 2004-03-30 | 2009-07-07 | Relypsa, Inc. | Ion binding polymers and uses thereof |
US8192758B2 (en) * | 2004-03-30 | 2012-06-05 | Relypsa, Inc. | Ion binding compositions |
US8282960B2 (en) | 2004-03-30 | 2012-10-09 | Relypsa, Inc. | Ion binding compositions |
KR101228233B1 (ko) | 2004-03-30 | 2013-01-31 | 리립사, 인크. | 이온 결합 중합체 및 이의 용도 |
US7854924B2 (en) | 2004-03-30 | 2010-12-21 | Relypsa, Inc. | Methods and compositions for treatment of ion imbalances |
US7429394B2 (en) | 2004-03-30 | 2008-09-30 | Relypsa, Inc. | Ion binding compositions |
EP3574896A1 (en) * | 2004-03-30 | 2019-12-04 | Relypsa, Inc. | Ion binding polymers and uses thereof |
US20050265955A1 (en) * | 2004-05-28 | 2005-12-01 | Mallinckrodt Inc. | Sustained release preparations |
EP1747776A1 (en) * | 2005-07-29 | 2007-01-31 | KRKA, tovarna zdravil, d.d., Novo mesto | Pharmaceutical composition comprising granular pantoprazole |
FR2891147B1 (fr) * | 2005-09-28 | 2007-12-07 | Ethypharm Sa | Comprimes orodispersibles de principes actifs amers |
AU2006294455B2 (en) | 2005-09-30 | 2013-06-20 | Relypsa, Inc. | Methods for preparing core-shell composites having cross-linked shells and core-shell composites resulting therefrom |
DE112006002618T5 (de) | 2005-09-30 | 2008-08-28 | Ilypsa Inc., Santa Clara | Verfahren und Zusammensetzungen zum selektiven Entfernen von Kaliumionen aus dem Gastrointestinaltrakt eines Säugers |
EP1834634A3 (en) * | 2006-03-08 | 2007-10-03 | Rentschler Pharma GmbH | Pharmaceutical multiple-unit composition |
EP1837016A3 (en) * | 2006-03-08 | 2008-01-02 | KRKA, tovarna zdravil, d.d., Novo mesto | Pharmaceutical multiple-unit composition |
KR101495146B1 (ko) | 2006-03-16 | 2015-02-24 | 트리스 파마 인코포레이티드 | 약물 - 이온교환 수지 복합체를 함유하는 변형 방출 제제 |
JP5661281B2 (ja) * | 2006-08-18 | 2015-01-28 | エボニック レーム ゲゼルシャフト ミット ベシュレンクテル ハフツングEvonik Roehm GmbH | 良好な水溶解性を有する作用物質のための作用物質の制御送達を有する医薬組成物 |
EP2044929A1 (en) * | 2007-10-04 | 2009-04-08 | Laboratorios del Dr. Esteve S.A. | Oral fast distintegrating tablets |
WO2010022380A2 (en) | 2008-08-22 | 2010-02-25 | Relypsa, Inc. | Linear polyol stabilized polyfluoroacrylate compositions |
US8287903B2 (en) | 2011-02-15 | 2012-10-16 | Tris Pharma Inc | Orally effective methylphenidate extended release powder and aqueous suspension product |
AU2011359405A1 (en) * | 2011-02-15 | 2013-08-22 | Tris Pharma, Inc. | Extended release powder and aqueous suspension comprising methylphenidate |
WO2014028610A1 (en) | 2012-08-15 | 2014-02-20 | Tris Pharma, Inc. | Methylphenidate extended release chewable tablet |
BR112015007749A2 (pt) | 2012-10-08 | 2017-07-04 | Relypsa Inc | métodos para tratamento de hipertensão , de hipercaliemia , e de doença renal crônica. |
US10245284B2 (en) * | 2015-08-19 | 2019-04-02 | Alpex Pharma S.A. | Granular composition for oral administration |
US11590228B1 (en) | 2015-09-08 | 2023-02-28 | Tris Pharma, Inc | Extended release amphetamine compositions |
WO2018063808A1 (en) | 2016-09-28 | 2018-04-05 | Dow Global Technologies Llc | Air treatment article |
US11590081B1 (en) | 2017-09-24 | 2023-02-28 | Tris Pharma, Inc | Extended release amphetamine tablets |
US20220257780A1 (en) * | 2019-10-10 | 2022-08-18 | Brillian Pharma Inc. | Micronized drug resinate-based pharmaceutical compositions and methods of preparation thereof |
CN114933344B (zh) * | 2022-05-16 | 2023-11-24 | 西北大学 | 一种双官能团酸性离子交换吸附剂去除废水中氟喹诺酮类抗生素的应用 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
LU63060A1 (ja) * | 1971-04-26 | 1971-08-26 | ||
US4808411A (en) * | 1987-06-05 | 1989-02-28 | Abbott Laboratories | Antibiotic-polymer compositions |
US4996047A (en) * | 1988-11-02 | 1991-02-26 | Richardson-Vicks, Inc. | Sustained release drug-resin complexes |
EP0943341A1 (en) * | 1998-02-18 | 1999-09-22 | Oscar Gold | Procedure to prepare granulated compositions that contain erythromycin macrolides and procedure to prepare pharmaceutical compositions that contain said macrolides |
-
2000
- 2000-01-07 EP EP00900315A patent/EP1140037A1/en not_active Withdrawn
- 2000-01-07 CA CA002355829A patent/CA2355829A1/en not_active Abandoned
- 2000-01-07 JP JP2000591981A patent/JP2002534374A/ja active Pending
- 2000-01-07 WO PCT/IE2000/000003 patent/WO2000040224A1/en not_active Application Discontinuation
- 2000-01-07 AU AU19982/00A patent/AU1998200A/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
CA2355829A1 (en) | 2000-07-13 |
JP2002534374A (ja) | 2002-10-15 |
WO2000040224A1 (en) | 2000-07-13 |
EP1140037A1 (en) | 2001-10-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU1998200A (en) | Multiparticulate oral dosage forms | |
HUP0203204A3 (en) | Oral dosage forms | |
ZA200202480B (en) | Oral dosage forms. | |
AU6089200A (en) | Rapid immediate release oral dosage form | |
AU3243300A (en) | Multiparticulate formulation | |
AU3977099A (en) | Controlled release oral dosage form | |
AU7657000A (en) | Toothbrush | |
AU2276801A (en) | Extended release oral dosage composition | |
AU2001253265A1 (en) | Oral treatment systems | |
AU5259100A (en) | Medicament | |
AU1071301A (en) | Pharmaceutical compounds | |
AU2905200A (en) | Toothbrush | |
GB2351272B (en) | Oral medicine dispenser | |
AU3736200A (en) | Toothbrush | |
AU2001259693A1 (en) | Oral devices | |
AU3120900A (en) | Lingualize occlusal bur | |
AU4402900A (en) | Toothbrush | |
AU4428000A (en) | Pulse-delivery oral compositions | |
AU2002352410A1 (en) | Improved oral medicine dispenser | |
AU7956700A (en) | Toothbrush | |
AU2913800A (en) | Toothbrush | |
AU2001296622A1 (en) | Oral devices | |
AU1277101A (en) | Toothbrush | |
GB9923045D0 (en) | New oral formulations | |
AU2002251448A1 (en) | Oral absorbed drugs |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |